Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Ingested Dual Balloon Encourages Weight Loss

By HospiMedica International staff writers
Posted on 12 Aug 2015
A novel non-surgical weight loss procedure aids people who either do not want or do not qualify for bariatric surgery.

The ReShape Integrated Dual Balloon System consists of two connected balloons that occupy space in the stomach, so that patients feel satiety with smaller portions of food. More...
The system is inserted via an endoscopic procedure; once in place, the two balloons are inflated using saline, and remain in the stomach for six months to help reduce hunger. During these first six months, and for the six months after the balloons are removed, patients receive comprehensive counseling and support services that include frequent in-office coaching sessions.

The ReShape provides a personalized pathway broken down into three phases over the 12 months. The first phase involves a personalized evaluation and education session. The two balloons are then inserted in the stomach in a 20 minute procedure. This is followed by personalized coaching, with a focus on healthy eating, exercise, and lifestyle habits, to maximize treatment success. The balloons are removed at six months, with six monthly sessions continuing onwards thereafter to set goals and track progress.

To help patients monitor their progress, a ReShape Patient Portal provides weight logging, food logging, activity tracking, goal setting, articles and recipes, community forums, and other important reminders. The portal can be accessed from a smartphone or tablet, and the Fitbit (San Francisco, CA, USA) wireless scale and activity tracker can be integrated as well to integrate all weight loss data in one place.

The ReShape Integrated Dual Balloon System is a product of ReShape Medical (San Clemente, CA, USA), and has been approved by the US Food and Drug Administration (FDA). It is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients with a body mass index (BMI) of 30–40 kg/m2, one or more obesity-related comorbidity conditions, and who have failed weight reduction with diet and exercise alone.

“Many Americans have struggled with a lack of effective weight loss options when their BMI is in the 30–40 range,” said John Morton, MD, MPH, president of the American Society for Metabolic and Bariatric Surgery (Gainesville, FL, USA). “Options like ReShape address a significant gap that exists between diet and exercise, weight loss medications and surgery, offering a minimally invasive, reversible option which we hope will promote long-term healthy habits.”

Related Links:

ReShape Medical
Fitbit
American Society for Metabolic and Bariatric Surgery



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Multi-Chamber Washer-Disinfector
WD 390
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.